Evelyne Houang

Title: The Innovative Contributions of Evelyne Houang

Introduction

Evelyne Houang is a notable inventor based in Queens, NY, who has made significant contributions to the field of medical research. With a total of two patents to her name, she has focused her work on developing small molecule antagonists that target human integrins, which play a crucial role in various diseases and conditions.

Latest Patents

Evelyne's latest patents include innovative methods for inhibiting human integrin (alpha-4) (beta-7). These patents disclose small molecule antagonists of human αβ integrin and outline methods for using them to treat a range of diseases and conditions. Her work in this area demonstrates her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Evelyne is currently employed at Morphic Therapeutics, Inc., where she continues to push the boundaries of research and innovation. Her expertise in integrin biology has positioned her as a key player in the development of new therapeutic strategies.

Collaborations

Throughout her career, Evelyne has collaborated with talented individuals such as Matthew Gregory Bursavich and Dan Cui. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Evelyne Houang's contributions to the field of medical research through her patents and work at Morphic Therapeutics, Inc. highlight her role as an influential inventor. Her innovative approaches to treating diseases through integrin inhibition are paving the way for future advancements in healthcare.